A Late-onset and Relatively Rapidly Progressive Case of Pure Spinal Form Cerebrotendinous Xanthomatosis with a Novel Mutation in the CYP27A1 Gene.
Cervical Cord
/ pathology
Chenodeoxycholic Acid
/ therapeutic use
Cholestanetriol 26-Monooxygenase
/ genetics
Cholestanol
/ blood
Drug Therapy, Combination
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
/ therapeutic use
Magnetic Resonance Imaging
Male
Middle Aged
Mutation, Missense
Spinal Cord
/ pathology
Spinal Diseases
/ diagnosis
Xanthomatosis, Cerebrotendinous
/ diagnosis
CYP27A1 gene
cerebrotendinous xanthomatosis
cholestanol
late onset
myelopathy
pure spinal form
Journal
Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241
Informations de publication
Date de publication:
15 Oct 2020
15 Oct 2020
Historique:
pubmed:
26
6
2020
medline:
4
3
2021
entrez:
26
6
2020
Statut:
ppublish
Résumé
A 61-year-old Japanese man with the pure spinal form of cerebrotendinous xanthomatosis developed dysesthesia of the lower limbs and gait disturbance at 57 years of age. At 61 years old, he was unable to walk without support. A neurological examination showed spasticity and sensory disturbance in the lower limbs. Spinal MRI showed long hyperintense lesions involving the lateral and posterior funiculus in the cervical and thoracic cord on T2-weighted images. His serum cholestanol level was markedly elevated. A CYP27A1 gene analysis identified two missense variants, p.R474W, and a novel p.R262C variant. Combination therapy with chenodeoxycholic acid and 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase decreased his serum cholestanol level.
Identifiants
pubmed: 32581172
doi: 10.2169/internalmedicine.5037-20
pmc: PMC7662043
doi:
Substances chimiques
Hydroxymethylglutaryl-CoA Reductase Inhibitors
0
Chenodeoxycholic Acid
0GEI24LG0J
Cholestanol
8M308U816E
CYP27A1 protein, human
EC 1.14.15.15
Cholestanetriol 26-Monooxygenase
EC 1.14.15.15
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2587-2591Références
J Lipid Res. 1994 Jun;35(6):1031-9
pubmed: 7915755
Science. 1999 May 21;284(5418):1362-5
pubmed: 10334992
BMC Neurol. 2016 Feb 09;16:21
pubmed: 26861945
Pract Neurol. 2015 Aug;15(4):280-3
pubmed: 25862734
Brain. 1999 Aug;122 ( Pt 8):1589-95
pubmed: 10430841
Intern Med. 2010;49(12):1127-31
pubmed: 20558929
J Biol Chem. 1991 Apr 25;266(12):7774-8
pubmed: 1708392
Eur J Neurol. 2011 Oct;18(10):1203-11
pubmed: 21645175
Arch Neurol. 1984 Sep;41(9):999-1001
pubmed: 6477238
J Lipid Res. 2001 Feb;42(2):159-69
pubmed: 11181744
J Hum Genet. 2018 Mar;63(3):271-280
pubmed: 29321515
J Inherit Metab Dis. 2015 Mar;38(2):363-4
pubmed: 25112387
J Biol Chem. 1991 Apr 25;266(12):7779-83
pubmed: 2019602
J Lipid Res. 1997 May;38(5):870-9
pubmed: 9186905
J Spinal Cord Med. 2016 Nov;39(6):726-729
pubmed: 25941960
Metabolism. 1991 Jul;40(7):741-6
pubmed: 1908036
N Engl J Med. 1984 Dec 27;311(26):1649-52
pubmed: 6504105